Longeveron Inc. — Investor Relations & Filings
Longeveron Inc. is a clinical-stage biotechnology company that develops cellular therapies for aging-related and life-threatening conditions. The company's lead investigational product, laromestrocel (Lomecel-B™), is a cell-based therapy designed to repair, regenerate, and restore damaged tissue. Longeveron's clinical development is focused on several key indications, including Hypoplastic Left Heart Syndrome (HLHS), a rare congenital heart defect in infants for which it has an orphan drug designation. Other primary clinical programs target Alzheimer's disease and Aging Frailty. For its Alzheimer's program, the U.S. FDA has granted laromestrocel both Regenerative Medicine Advanced Therapy (RMAT) and Fast Track designations. The company's research aims to improve healthspan by addressing unmet medical needs.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| ARS | 2026-05-20 | English | |
| DEFINITIVE ADDITIONAL MATERIALS | 2026-05-20 | English | |
| PROXY STATEMENT | 2026-05-20 | English | |
| 10-Q - Longeveron Inc. (0001721484) (Filer) | 2026-05-13 | English | |
| 424B3 - Longeveron Inc. (0001721484) (Filer) | 2026-04-17 | English | |
| 8-K - Longeveron Inc. (0001721484) (Filer) | 2026-04-10 | English |
Browse filings by year
9 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46691597 | ARS | 2026-05-20 | English | ||
| 46691649 | DEFINITIVE ADDITIONAL MATERIALS | 2026-05-20 | English | ||
| 46691779 | PROXY STATEMENT | 2026-05-20 | English | ||
| 45759933 | 10-Q - Longeveron Inc. (0001721484) (Filer) | 2026-05-13 | English | ||
| 34662335 | 424B3 - Longeveron Inc. (0001721484) (Filer) | 2026-04-17 | English | ||
| 34028758 | 8-K - Longeveron Inc. (0001721484) (Filer) | 2026-04-10 | English | ||
| 34026781 | S-1 - Longeveron Inc. (0001721484) (Filer) | 2026-04-10 | English | ||
| 33042625 | 8-K - Longeveron Inc. (0001721484) (Filer) | 2026-03-25 | English | ||
| 33040616 | D - Longeveron Inc. (0001721484) (Filer) | 2026-03-25 | English | ||
| 33034971 | 8-K - Longeveron Inc. (0001721484) (Filer) | 2026-03-24 | English | ||
| 32897265 | 8-K - LONGEVERON INC. (0001721484) (Filer) | 2026-02-13 | English | ||
| 31462769 | SCHEDULE 13G/A Filing | 2026-02-10 | English | ||
| 13071948 | PRIMARY DOCUMENT | 2026-01-07 | English | ||
| 13071949 | PRIMARY DOCUMENT | 2026-01-07 | English | ||
| 13071950 | PRIMARY DOCUMENT | 2026-01-07 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
89bio, Inc.
Clinical-stage biopharma developing therapies for liver and…
|
ETNB | US | Manufacturing |
|
Aardvark Therapeutics, Inc.
Clinical-stage biopharma developing therapeutics for hunger…
|
AARD | US | Manufacturing |
|
Aarey Drugs & Pharmaceuticals Ltd
Manufactures APIs and chemical intermediates for global pha…
|
AAREYDRUGS | IN | Manufacturing |
|
Aarti Drugs Limited
Produces APIs, pharma intermediates, and specialty chemical…
|
AARTIDRUGS | IN | Manufacturing |
|
Aarti Pharmalabs Limited
Manufacturer of APIs, intermediates, and xanthines with glo…
|
AARTIPHARM | IN | Manufacturing |
|
AAYUSH WELLNESS LIMITED
Develops and markets herbal formulations, supplements, and …
|
539528 | IN | Manufacturing |
|
Ab&B Bio-Tech CO., LTD. JS
Biopharmaceutical company engaged in the R&D and commercial…
|
2627 | HK | Manufacturing |
|
Abbisko Cayman Limited
Clinical-stage biopharma focused on discovering and develop…
|
2256 | KY | Manufacturing |
|
Abbott India Ltd.
Provides pharmaceutical solutions in gastroenterology, card…
|
ABBOTINDIA | IN | Manufacturing |
|
ABBOTT LABORATORIES
Global healthcare company in medical devices, diagnostics, …
|
ABT | US | Manufacturing |
Longeveron Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35052/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35052 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35052 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35052 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35052}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Longeveron Inc. (id: 35052)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.